Follow the progress of Hemolens Diagnostics
This website contains information intended only for persons professionally dealing with medical devices (e.g. for persons performing medical professions, for persons dealing with the distribution of medical devices). Please confirm that you are a medical device professional to proceed.
Follow the progress of Hemolens Diagnostics
July 22, 2025
Hemolens Diagnostics® has become an official Partner of the LifeScience Krakow Cluster, joining a dynamic network that connects scientific institutions and businesses from across the Life Science sector.
Founded in 2006, the LifeScience Krakow Cluster was established as an initiative of institutions and companies from the Southern Poland macroregion to support and develop innovative activities in the fields of Life Sciences and biotechnology.
Cluster Partners work together to enhance economic efficiency and entrepreneurship, both regionally and nationally. The Cluster brings together companies, academic institutions, research centers, business support organizations, and public authorities, creating an ecosystem that nurtures innovation, cooperation, and sustainable growth.
The Cluster is structured around six core working groups:
Today, the Cluster includes over 100 members, with new partners joining regularly.
The Cluster’s core mission is to build strong, long-term relationships and foster strategic collaboration within the Life Science sector by connecting individuals, companies, research institutions, academia, and public organizations.
By encouraging knowledge-sharing and joint initiatives, the Cluster enables more effective use of resources and expertise. Its activities focus on supporting innovation and entrepreneurship by creating a favorable environment for technology transfer and for bringing research and development outcomes to market.
Partners collaborate to unlock the potential of the Life Science sector and respond proactively to the opportunities emerging from a knowledge-based and innovation-driven economy.
As a Partner of the LifeScience Krakow Cluster, Hemolens Diagnostics® gains access to a vibrant network of academic and business entities working in the Life Sciences.
This collaborative environment brings together:
“At Hemolens Diagnostics®, we focus on developing innovative, non-invasive diagnostic tools in cardiology – solutions that have a real impact on clinical decision-making. In creating our solutions, we combine advanced technologies with the expertise of specialists from diverse fields, including medicine, science, and engineering. Only such an interdisciplinary approach enables us to develop tools that not only accelerate diagnostics but also enhance the efficiency of entire healthcare systems – by reducing the need for invasive procedures and unnecessary hospitalizations. Joining the Life Science Kraków Cluster is another important step for us. We believe that collaboration with universities, research institutions, and companies in the Life Sciences sector will accelerate the implementation of solutions that support the digital transformation of healthcare and the development of modern, sustainable, data-driven medicine.”– says Paweł Paluch, Commercial Director at Hemolens Diagnostics®.
Hemolens Diagnostics® specializes in developing and delivering advanced technologies for noninvasive cardiac diagnostics. The company’s platform may support healthcare professionals in making more informed decisions in the diagnosis and treatment of coronary artery disease.
Its potential applications include reducing the number of invasive procedures, improving operational efficiency in medical facilities, and optimizing the use of healthcare system resources.
